From: JoAnne Wilkins [jswilkins@lisco.com] Sent: Saturday, March 31, 2001 10:24 PM To: fdadockets@oc.fda.gov Subject: MANDATORY LABELING OF GENETICALLY ENGINEERED FOODS!!!!!!!! Dear FDA, I want you to know that I only purchase organic foods since learning about the genetically engineered foods that are allowed in our food system without anyone's knowledge. While the best solution would be to eliminate genetically engineered foods all together, at the very least THEY MUST BE LABELED. In addition, they must be tested -- it is the poorest segment of our population that will suffer because they do not have the means to purchase organic produce (I estimate my food bill has doubled since going to entirely organic foods, which is the only way I can be sure that the foods are NOT genetically engineered). I therefore request that: * The FDA must require mandatory pre-market comprehensive environmental review. Unlike conventional pollutants, where a given amount of pollutant causes a limited amount of damage, a small number of mutant genes could have a population explosion and reproduce forever, causing unlimited and irreparable damage. * The FDA must require mandatory pre-market long-term health testing. GE products could be toxic, cause allergic responses, have lower nutritional value, and compromise immune responses in consumers. * The FDA must require mandatory labeling of GE products. Without mandatory labeling, neither consumers nor health professionals will know if an allergic or toxic reaction was the result of a genetically engineered food. Consumers would be deprived of the critical knowledge needed to hold food producers liable should any of these novel products be hazardous. Sincerely, JoAnne, Mark, Ben, Newlin and Tahra Wilkins * The FDA must end its cozy relationship with the industries it purports to be regulating. People have been allowed to work for a biotech company, then work for the FDA writing the regulatory rules on that company's product, then go back to working for the company. Ninety-two percent of FDA advisory committee meetings had at least one conflict of interest.